CVS to Pay $315M Over Allegations of Unlawful Opioid Dispensing
Key Summary
Federal authorities have secured a $315 million settlement with CVS Pharmacy Inc. over allegations of improper opioid dispensing and submitting false claims to federal healthcare programs. The US Department of Justice alleges CVS filled excessive prescriptions, early refills, and dangerous combinations despite red flags from suspected pill-mill doctors. The company will add monitoring safeguards and establish a reporting hotline under a separate DEA agreement.
Settlement Agreement
Federal authorities have secured a $315 million settlement with CVS Pharmacy Inc. over allegations of improper opioid dispensing and submitting false claims to federal healthcare programs. The US Department of Justice alleges CVS filled excessive prescriptions, early refills, and dangerous combinations despite red flags from suspected pill-mill doctors.
CVS Pharmacy Inc., US Department of Justice, Associate Attorney General Stanley E. Woodward Jr.
Regulatory Enforcement
3
• CVS Pharmacy Inc. has agreed to pay $315 million to settle allegations of improper opioid dispensing and submitting false claims to federal healthcare programs. • The US Department of Justice alleges CVS filled excessive prescriptions, early refills, and dangerous combinations despite red flags from suspected pill-mill doctors. • The company will add monitoring safeguards and establish a reporting hotline under a separate DEA agreement.